International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 260-268 doi: 10.5281/zenodo.16718758
Original Article
Blood Lipid Profiles as Biomarkers for Disease Activity In Patients with Severe Ulcerative Colitis: A Cross-Sectional Observational Study
 ,
 ,
 ,
Published
July 31, 2025
Abstract

Background: Ulcerative colitis (UC) is a chronic inflammatory condition characterized by periods of activity and remission. Identifying accessible biomarkers that correlate with disease activity could aid in disease monitoring. This study evaluated the potential of lipid profile components as biomarkers for disease activity in patients with severe UC.

Methods: A retrospective analysis was conducted on 220 patients diagnosed with severe UC. Fasting lipid profiles—including total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TGs)—were compared between patients in active and remission phases. Correlation analyses were performed between lipid values and C-reactive protein (CRP) levels as well as Mayo scores. Logistic regression and ROC curve analysis assessed the predictive performance of lipid parameters for active disease.

Results: No statistically significant differences were found in TC, LDL-C, HDL-C, or TG levels between patients with active UC and those in remission (all p-values > 0.39). Correlations between lipid markers and CRP or Mayo scores were weak and nonsignificant (HDL-C and CRP: r = 0.01, p = 0.87; TGs and CRP: r = –0.05, p = 0.63). None of the lipid components were independent predictors of disease activity in multivariate analysis. The combined lipid model yielded a modest discriminative performance (AUC = 0.58).

Conclusion: Serum lipid profiles did not significantly differ between active and remission states of severe UC and showed limited utility as standalone biomarkers of disease activity. Further prospective studies are warranted to explore alternative noninvasive markers for monitoring UC severity.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
2538 Views
474 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved